These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16108150)

  • 21. Uterine tumors resembling ovarian sex cord tumors: an update.
    Czernobilsky B
    Int J Gynecol Pathol; 2008 Apr; 27(2):229-35. PubMed ID: 18317219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 May; 30(5):614-24. PubMed ID: 16699316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
    Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical staging of ovarian cancer].
    Kato T; Yakushiji M
    Sanfujinka No Jissai; 1971 Dec; 20(13):1223-30. PubMed ID: 5172379
    [No Abstract]   [Full Text] [Related]  

  • 25. Histological pattern of ovarian tumors and their age distribution.
    Jha R; Karki S
    Nepal Med Coll J; 2008 Jun; 10(2):81-5. PubMed ID: 18828427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline tumors of the ovary and peritoneal implants.
    Denkert C; Dietel M
    Verh Dtsch Ges Pathol; 2005; 89():84-91. PubMed ID: 18035677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm.
    Irving JA; Young RH
    Am J Surg Pathol; 2009 Mar; 33(3):367-75. PubMed ID: 18971779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viewing ovarian cancer as a "chronic disease": what exactly does this mean?
    Markman M
    Gynecol Oncol; 2006 Feb; 100(2):229-30. PubMed ID: 16226801
    [No Abstract]   [Full Text] [Related]  

  • 30. Histologic subtypes of ovarian carcinoma: an overview.
    Soslow RA
    Int J Gynecol Pathol; 2008 Apr; 27(2):161-74. PubMed ID: 18317227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonic evaluation and classification of ovarian tumors.
    Vera MT; Okai T; Mukubo M; Kozuma S; Maeda T; Mizuno M
    Asia Oceania J Obstet Gynaecol; 1986 Mar; 12(1):89-97. PubMed ID: 3521568
    [No Abstract]   [Full Text] [Related]  

  • 33. High-grade serous carcinoma of the ovary.
    Westfall D; Roma AA; Silva EG
    Ann Diagn Pathol; 2009 Aug; 13(4):285-90. PubMed ID: 19608089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular matrix of ovarian tumors.
    Ricciardelli C; Rodgers RJ
    Semin Reprod Med; 2006 Sep; 24(4):270-82. PubMed ID: 16944424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classification and treatment of ovarian cancer].
    Sugiyama T; Kou T
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):228-232. PubMed ID: 18372512
    [No Abstract]   [Full Text] [Related]  

  • 36. My approach to and thoughts on the typing of ovarian carcinomas.
    McCluggage WG
    J Clin Pathol; 2008 Feb; 61(2):152-63. PubMed ID: 17704261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Borderline ovarian tumors: an update].
    Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
    Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systems.
    Singh N; Ayhan A; Menon U; Chin Aleong JA; Faruqi AZ; Gayther SA; Jacobs IJ
    Histopathology; 2008 Feb; 52(3):393-5. PubMed ID: 18081817
    [No Abstract]   [Full Text] [Related]  

  • 40. Ovarian carcinoma pathology and genetics: recent advances.
    Gilks CB; Prat J
    Hum Pathol; 2009 Sep; 40(9):1213-23. PubMed ID: 19552940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.